Grupo de investigación cardiovascular
GRINCAR
Complexo Hospitalario Universitario de Santiago
Santiago de Compostela, EspañaPublicaciones en colaboración con investigadores/as de Complexo Hospitalario Universitario de Santiago (28)
2024
-
Incidence and causes of hospitalization in patients with transthyretin (ATTR-CA) and light chain (AL-CA) cardiac amyloidosis
Medicina Clinica, Vol. 162, Núm. 7, pp. e1-e7
-
Prognostic value of the tricuspid annular plane systolic excursion/systolic pulmonary artery pressure ratio in cardiac amyloidosis
Revista Espanola de Cardiologia, Vol. 77, Núm. 8, pp. 634-644
2023
-
Cardiogenic shock code 2023. Expert document for a multidisciplinary organization that allows quality care
Revista Espanola de Cardiologia, Vol. 76, Núm. 4, pp. 261-269
2022
-
Association of rhinitis with asthma prevalence and severity
Scientific Reports, Vol. 12, Núm. 1
-
Beta-Blocker Exposure and Survival in Patients With Transthyretin Amyloid Cardiomyopathy
Mayo Clinic Proceedings, Vol. 97, Núm. 2, pp. 261-273
-
Cardiac amyloidosis: Description of a series of 143 cases
Medicina Clinica, Vol. 159, Núm. 5, pp. 207-213
-
Clinical characteristics and prognosis of myocardial infarction with non-obstructive coronary arteries: A prospective single-center study
Cardiology Journal, Vol. 29, Núm. 5, pp. 798-806
-
Prevalence, Incidence, and Outcomes of Hyperkalaemia in Patients with Chronic Heart Failure and Reduced Ejection Fraction from a Spanish Multicentre Study: SPANIK-HF Design and Baseline Characteristics
Journal of Clinical Medicine, Vol. 11, Núm. 5
-
Serum potassium dynamics during acute heart failure hospitalization
Clinical Research in Cardiology, Vol. 111, Núm. 4, pp. 368-379
-
Syncope in patients with transthyretin amyloid cardiomyopathy: clinical features and outcomes
Postgraduate Medicine, Vol. 134, Núm. 4, pp. 420-428
2021
-
A 3-Biomarker 2-Point-Based Risk Stratification Strategy in Acute Heart Failure
Frontiers in Physiology, Vol. 12
-
Differences in the clinical profile and management of atrial fibrillation according to gender. Results of the registro gallego intercéntrico de fibrilación auricular (regueifa) trial
Journal of Clinical Medicine, Vol. 10, Núm. 17
-
Persistent pulmonary hypertension in corrected valvular heart disease: Hemodynamic insights and long-term survival
Journal of the American Heart Association, Vol. 10, Núm. 2, pp. 1-21
-
Rationale, design and basal characteristics of REGUEIFA study (Multicenter Registry of Atrial Fibrillation in Galicia)
REC: CardioClinics, Vol. 56, Núm. 3, pp. 197-207
2020
-
One-year prognosis of patients with heart failure in Spain. ESC-EORP-HFA Heart Failure Long-Term Registry
REC: CardioClinics, Vol. 55, Núm. 4, pp. 207-216
-
Prevalence, clinical profile and prognostic implications of interatrial block in patients admitted for heart failure
REC: CardioClinics, Vol. 55, Núm. 3, pp. 155-164
2019
-
Colombian consensus on advanced heart failure: Heart Failure, Heart Transplant and Pulmonary Hypertension Section of Colombian Society of Cardiology and Cardiovascular Surgery
Revista Colombiana de Cardiologia, Vol. 26, pp. 3-24
-
Patient-Associated Predictors of 15- and 30-Day Readmission After Hospitalization for Acute Heart Failure
Current Heart Failure Reports, Vol. 16, Núm. 6, pp. 304-314
2018
-
Rationale, design and preliminary results of the GALIPEMIAS study (prevalence and lipid control of familial dyslipidemia in Galicia, northwest Spain)
International Journal of Clinical Practice, Vol. 72, Núm. 9
-
Sildenafil for improving outcomes in patients with corrected valvular heart disease and persistent pulmonary hypertension: A multicenter, double-blind, randomized clinical trial
European Heart Journal, Vol. 39, Núm. 15, pp. 1255-1264